Loading data for IMDX — first visit, this takes a few seconds.

Insight Molecular Diagnos...

NasdaqCM: IMDX · Real-Time Price · USD
4.34
+0.04 (0.93%)
At close: Aug 21, 2026, 8:00 PM
4.34
+0.00%
After-hours: 4:10 PM

The price, the headline numbers and the latest news, in one place.

Insight Molecular Diagnostics Inc. (IMDX) Stock Price, Analysis & Data

0.93%

No data available

Bid3.17
Market Cap142.02M
Revenue (ttm)1.67M
Net Income (ttm)-49.36M
1.82
-1.53
n/a
-5.17
P/B (ttm)-6.65
P/S (ttm)85.04
Earnings DateNov 9, 2026
Ask5.55
Volume37,984
Avg. Volume (20D)233,920
Open4.40
Previous Close4.30
Day's Range4.31 - 4.46
52-Week Range2.33 - 8.51
Analystn/a
Price Targetn/a
Dividendsn/a
Ex-Dividend Daten/a

About IMDX

Insight Molecular Diagnostics Inc. operates as a precision diagnostics company in the United States and internationally. The company develops and commercializes laboratory developed tests, kitted research use only tests, and kitted clinical tests. It is developing DetermaCNI, a blood-based monitoring tool that detects progression early after one cycle cancer treatment; and DetermaIO, a gene expression test that assesses the tumor microenvironment...

Sector Healthcare
IPO Date Dec 30, 2015
Employees 55
Stock Exchange NasdaqCM
Ticker Symbol IMDX
Full Company Profile

Financial Performance

In 2025, Insight Molecular Diagnostics's revenue was 4.05M, an increase of 115.58% compared to the previous year's 1.88M. Earnings were -50.22M, a decrease of -17.21%.

Financial Statements

Earnings Surprise

Insight Molecular Diagnostics has released their quarterly earnings on Aug 10, 2026:
  • Revenue of $32K misses estimates by $0, with -98.50% YoY decline.
  • EPS of -0.24 misses estimates by -0.01, with 20.00% YoY growth.
Insight Molecular Diagnostics Inc. is scheduled to release its earnings on Nov 9, 2026, during market hours.
Analysts project revenue of ... Upgrade